December 2024 - Cholinesterase Inhibitors drug patent information, global generic entry, market access

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	077131-003	Oct 22, 2007		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Alembic Pharms Ltd	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	091689-004	Jun 12, 2012	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Chartwell Rx	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	207797-002	Sep 28, 2017	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Cadila Pharms Ltd	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	203844-001	Feb 13, 2017	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Sun Pharm	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	077131-004	Oct 22, 2007		DISCN	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Chartwell Rx	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	207797-003	Sep 28, 2017	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Macleods Pharms Ltd	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	203148-001	Aug 22, 2014	AB	RX	No	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration